Search
forResearch 10 of 1000+
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1–30 September 2016
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Persistierende Wundheilungsstörungen nach Lokaltherapie von Feldkanzerisierung des Capillitiums mit Imiquimod oder Diclofenac
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Hair and Scalp Health in Modern Lifestyle: Challenges and Natural Solutions
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
Community 10 of 420
- So why did the first pyrilutamide phase III fail?
- TH07 by Triple Hair entering phase III trial
- Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
- Breezula Phase III 12-Month Data Released by Cosmo Pharma
- Pyrilutamide phase III clinical trial results released
- What the Breezula Phase III results mean & realistic timeline
- Breezula 6 Month Topline Phase III Results Released
- Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says
- Kintor long term safety phase 3
- KX826 New Phase 3 Trial In China for 2025: 1.0% concentration
Learn
— no results
Try a deeper search in learn →